A technique that transforms immune cells into cancer-seeking bloodhounds may overcome a roadblock that has hampered ...

A new approach engineers immune cells to recognize byproducts of cancer cells to trigger migration toward the tumor.

CD8 + cytotoxic T lymphocytes (CTLs) serve as central effectors in cancer immunotherapy by directly eliminating tumor cells. However, current clinical therapies face significant limitations. These ...

Immune cells are vigilant sentinels stationed at their tissue posts, such as the skin, lungs, or gut, or circulating in the bloodstream. Their presence and ability to quickly mobilize are key defenses ...